Discover our new webpage dedicated to 90 years of HA
and download our White paper now!
Press releases
September 14, 2021
BMG Pharma and HTL sign a development agreement
The agreement between BMG Pharma and HTL will allow BMG Pharma to develop and commercialize injectable products with Sodium Hyaluronate Lipoate Formate (SHLF). BMG Pharma through its patented Hyaluromimethic® Technology works on SHLF to develop solutions in aesthetic dermatology, ophthalmology, and arthrosis.
– Thanks to this agreement, BMG Pharma will globally develop new formulations of its injectable products, always with high levels of quality, stability, and safety standards.
Read more below
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Articles November 14, 2024Discover our new webpage dedicated to 90 years of HA and download our White Paper!
and download our White paper now!
-
Articles October 8, 2024HTL Biotechnology at CPHI Milano
As the leading global event for the pharmaceutical industry, CPHI Milan brought together key stakeholders from across the sector to foster connections and innovation.
-
Articles October 4, 20241st symposium for HTL Biotechnology at MAIS congress
As a key event for regenerative medicine and biotech innovation, the MAIS Congress in Marbella brought together leading professionals to explore the latest advancements in the field. A unique opportunity to share with the medical aesthetic community our biopolymers platform.